Boston | October 20-21, 2026
Powerful Community, Fresh Ideas
Veeva Basics Trail Map
Veeva Basics
Monday, October 19
Tuesday, October 20
Hear from emerging biotech C-suite executives in a panel discussion on today’s operational challenges and the innovations redefining the industry. Learn how these three leaders mitigate risk, optimize resources, and create enduring partnerships.
Discover how a top biopharma leverages AI to reshape its regulatory operations. Gain insight into Veeva’s AI vision and how innovations will work together to augment teams, accelerate processes, and transform regulatory work.
Top biopharma unified end-to-end global safety operations and safety science with the full Veeva Safety Suite. Hear how it eliminated manual processes and complex integrations between legacy systems, improved operational efficiency, and enabled full traceability of signals back to source data for easier benefit-risk analysis.
Discover how embracing Veeva Basics early helps eliminate complex software configurations and secure an inspection-ready foundation from Day 1. This session covers leveraging system standardization and ensuring regulatory compliance faster.
Review recent enhancements to Veeva Registrations, Veeva Submissions, Veeva Submissions Publishing, and Veeva Submissions Archive, along with this year’s roadmap priorities. Updates include Vault AI for Regulatory, Labeling, eCTD 4.0, Active Dossier, Global Content Plans, and other capabilities that streamline data management and improve end-to-end regulatory processes.
Hear what’s planned for the Veeva Safety application, including automation and AI capabilities to improve process efficiency, increase data quality, and simplify global compliance.
In this session, a biotech customer shares how shifting away from a customization mindset to standardization with Veeva Basics establishes a highly unified organization. They detail their transition to industry best practices and creating operational efficiencies.
See the future of agentic regulatory organizations in action. Experience Veeva RIM’s newest capabilities through demonstrations and previews around how Vault AI, Falcon, and Lexx are evolving to solve critical regulatory challenges.
Clinical-stage biopharma redesigned safety to leverage modern best practices. Moving from heavily customized to an industry standard in-house solution, the company is working more effectively with its CRO partner and gaining greater PV insight while scaling operations to prepare for commercialization.
The Veeva Basics Product Team will demonstrate how native application connectivity eliminates data silos across Quality, Clinical, and Regulatory operations. This interactive showcase features our highest-impact application spotlights, seamless cross-functional workflows, and a first look at upcoming out-of-the-box AI capabilities.
Learn how biopharmas are building a high-quality data foundation to move beyond document-centric processes. Discover how a data-driven approach helps proactively manage regulatory changes, increase confidence in submission data, and improve global regulatory operations.
Examine how the RegOps role has expanded to include submission management, data strategy, system ownership, and cross-functional leadership. Learn how evolving regulations and technology are reshaping the role.
Wednesday, October 21
An emerging biotech explores how adopting Veeva QMS Basics cultivates a modern quality culture focused on people and mindset. Discover actionable change management strategies to drive ongoing process adherence and inspire teams to leverage new QMS workflows to accelerate growth.
Gain practical insights from biopharmas as they share approaches to identify and prioritize use cases for Vault AI, early lessons learned, and plans for scaling adoption.
Discover how biopharmas are using Veeva Registrations to build a robust data foundation, giving the business greater ownership and visibility into its data.
Get a first look at new features for safety process and content management, advanced reporting, and signal detection. See how these enhancements enable more efficient global processes, deeper patient insights, and better informed decision-making.
An emerging biotech demonstrates bringing regulatory publishing in-house to eliminate unpredictable bottlenecks and fragmented data. Learn how unification across your regulatory applications enables a faster, stress-free strategy of continuous submissions for lean teams.
Hear how a top biopharma implemented Global Content Plans, reducing the time and effort required for global submissions.
Discover how to demonstrate the value of continuous publishing. Hear best practices for managing publishing processes across internal and external teams to improve efficiency, collaboration, and submission readiness.
Biopharma modernized management of its pharmacovigilance agreements (PVAs) by centralizing content and automating global partner obligation oversight. Explore how a digital solution improves partner adherence, inspection readiness, and scalability.
A clincal stage biotech breaks down how bringing clinical operations in-house is achievable for growing biotechs. Hear about reclaiming direct data ownership to give your team control over real-time study metrics while establishing a scalable foundation from Day 1.
Learn how biopharmas are reducing duplication, increasing visibility, and simplifying health authority interactions using Veeva RIM and the Accumulus connector.
Discover how two, top biopharmas are relieving the downstream burden on publishers and accelerating high-volume regulatory submissions with Veeva Submissions Publishing.